Study highlights predictors of cognitive decline in early Alzheimer’s disease Older age, female gender, irregular heart rhythms and daily activity levels can help predict how much cognitive function in Alzheimer’s…
Beyond neurons: Glial cells identified as key players in Alzheimer’s disease Memory loss, confusion, speech problems – Alzheimer’s disease is the most common cause of dementia, affecting approximately 35 million people…
Emory researchers offer a new perspective on the mechanism behind Alzheimer’s disease New findings from Emory University challenge existing theories about the origins of Alzheimer’s disease, the leading cause of dementia in…
New technique reveals abnormalities in motor neurone disease Pathological abnormalities associated with motor neuron disease have been identified using a new technique developed at the University of Birmingham.…
New lab technique captures aging effects in Alzheimer’s disease development Researchers at Washington University School of Medicine in St. Louis have developed a way to capture the effects of aging…
FDA approves AChEI ALPHA-1062 for Alzheimer’s disease treatment On July 29, 2024, the US FDA approved Alpha Cognition Inc.’s ALPHA-1062 (Zunveyl).®), an Acetylcholinesterase (AChE) inhibitor, for the treatment…
